GlassScriptPhysician profile
Alexander Crawford
NPI 1083249346
$3,228.38
in general payments reported to CMS, 2019-2025
15 companies · $1,040 in 2025
The $1,040 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,416 · 2023: $324 · 2024: $449 · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,312.99 | 2022-2024 | |
| Stryker Corporation | $1,185.34 | 2022-2025 | Mako, Axsos, T2 |
| Acera Surgical, INC. | $211.45 | 2025 | Restrata Wound Matrix |
| Alphatec Spine, INC | $144.25 | 2023 | |
| Checkpoint Surgical, INC | $81.05 | 2025 | Checkpoint Stimulators |
| Vertex Pharmaceuticals Incorporated | $43.13 | 2024 | |
| Biocomposites INC | $39.19 | 2025 | Stimulan |
| P Bar Medical LLC | $38.81 | 2025 | |
| Polynovo North America LLC | $36.65 | 2024 | Novosorb Btm |
| Solventum Corporation | $33.24 | 2024 | Activ.A.C., Spoton, Prevena |
| Organogenesis INC. | $28.99 | 2024 | Puraply Am |
| Heron Therapeutics, INC. | $24.21 | 2025 | Zynrelef |
| Boston Scientific Corporation | $24.05 | 2024 | |
| Ethicon US, LLC | $20.20 | 2024 | Vistaseal, Dermabond, Stratafix |
| Depuy Synthes Sales INC. | $4.83 | 2024 | Motoband, Fibergraft Aeridyan Matrix, Va-Lcp |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Crawford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.